Jennifer Wu, PhD, Founder and President
Dr. Wu is a leading global expert and visionary in the area of immuno-oncology. She has prior experience with biotechnology development and has previously served as Scientific Liaison and Section Director at several leading biotechnology companies. Dr. Wu was instrumental in securing NIH funding and achieving early development milestones for CanCure technologies. Dr. Wu is also currently a Professor at Northwestern University Feinberg school of Medicine and Robert H. Lurie Comprehensive Cancer Center.
Grant Risdon, PhD, Senior Manager of Research and Business Development
Dr. Risdon holds a PhD and post-doctoral training in the field of immuno-oncology. He has over 15 years of corporate development and technology management experience in the biopharmaceutical industry.
Eddie Xing MD Clinical Development Consultant
Dr. Xing brings more than 20 years of medical expertise to the CanCure team. Dr. Xing has a wealth of experience in conducting clinical research and trial management in oncology and internal medicine. His most recent work features the creation of study designs, protocol development and implementation, and medical monitoring of global clinical trials for a new anti-PD-1 antibody that was licensed by Incyte Corporation.